Despite the success of Accelerated Approval for cancer drugs, I have talked with patients and innovators and investors, and they indicate that some in FDA intend to limit the use of the Accelerated Approval pathway for cancer drugs.
Pitts expresses concern over potential limitations on Accelerated Approval for cancer drugs.
Share
More from Joe Pitts
It seems illogical that the USDA would be given the exclusive authority to oversee and regulate catfish only while the FDA regulates all other seafood.
It is embarrassing that in the most capable country in the world, in the most powerful elected bodies in the world that we effectively have done almost nothing to improve the health care of Americans since this law has been passed.
Because of the Affordable Care Act, now over 20 million people in this country who were in that situation literally overnight are no longer in that situation.
The jurisdictional grab serves only to shield catfish farmers against competition at the expense of U.S. consumers.
Other voices in this conversation
